Literature DB >> 24409050

Current management of fecal incontinence: choosing amongst treatment options to optimize outcomes.

Julie Ann M Van Koughnett1, Steven D Wexner1.   

Abstract

The severity of fecal incontinence widely varies and can have dramatic devastating impacts on a person's life. Fecal incontinence is common, though it is often under-reported by patients. In addition to standard treatment options, new treatments have been developed during the past decade to attempt to effectively treat fecal incontinence with minimal morbidity. Non-operative treatments include dietary modifications, medications, and biofeedback therapy. Currently used surgical treatments include repair (sphincteroplasty), stimulation (sacral nerve stimulation or posterior tibial nerve stimulation), replacement (artificial bowel sphincter or muscle transposition) and diversion (stoma formation). Newer augmentation treatments such as radiofrequency energy delivery and injectable materials, are minimally invasive tools that may be good options before proceeding to surgery in some patients with mild fecal incontinence. In general, more invasive surgical treatments are now reserved for moderate to severe fecal incontinence. Functional and quality of life related outcomes, as well as potential complications of the treatment must be considered and the treatment of fecal incontinence must be individualized to the patient. General indications, techniques, and outcomes profiles for the various treatments of fecal incontinence are discussed in detail. Choosing the most effective treatment for the individual patient is essential to achieve optimal outcomes in the treatment of fecal incontinence.

Entities:  

Keywords:  Artificial bowel Sphincter; Biofeedback; Fecal incontinence; Sacral nerve stimulation; Sphincteroplasty; Treatment

Mesh:

Year:  2013        PMID: 24409050      PMCID: PMC3882396          DOI: 10.3748/wjg.v19.i48.9216

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  161 in total

1.  Long-term results of modified graciloplasty for sphincter replacement after rectal excision.

Authors:  H. R Rosen; C Urbarz; G Novi; G Zöch; R Schiessel
Journal:  Colorectal Dis       Date:  2002-07       Impact factor: 3.788

2.  Injectable silicone biomaterial for fecal incontinence caused by internal anal sphincter dysfunction is effective.

Authors:  J J Tjandra; J F Lim; R Hiscock; P Rajendra
Journal:  Dis Colon Rectum       Date:  2004-12       Impact factor: 4.585

3.  The Secca procedure for the treatment of fecal incontinence: definitive therapy or short-term solution.

Authors:  Christine J Parisien; Marvin L Corman
Journal:  Clin Colon Rectal Surg       Date:  2005-02

4.  Preliminary report: the antegrade continence enema.

Authors:  P S Malone; P G Ransley; E M Kiely
Journal:  Lancet       Date:  1990-11-17       Impact factor: 79.321

5.  Artificial anal sphincter: prospective clinical and manometric evaluation.

Authors:  P A Lehur; J V Roig; M Duinslaeger
Journal:  Dis Colon Rectum       Date:  2000-08       Impact factor: 4.585

6.  Supplementation with dietary fiber improves fecal incontinence.

Authors:  D Z Bliss; H J Jung; K Savik; A Lowry; M LeMoine; L Jensen; C Werner; K Schaffer
Journal:  Nurs Res       Date:  2001 Jul-Aug       Impact factor: 2.381

7.  Long-term follow-up of dynamic graciloplasty for faecal incontinence.

Authors:  M J Thornton; M L Kennedy; D Z Lubowski; D W King
Journal:  Colorectal Dis       Date:  2004-11       Impact factor: 3.788

8.  Postanal repair for fecal incontinence--is it worthwhile?

Authors:  H Matsuoka; C Mavrantonis; S D Wexner; L Oliveira; R Gilliland; A Pikarsky
Journal:  Dis Colon Rectum       Date:  2000-11       Impact factor: 4.585

Review 9.  Surgery for faecal incontinence in adults.

Authors:  Steven R Brown; Himanshu Wadhawan; Richard L Nelson
Journal:  Cochrane Database Syst Rev       Date:  2010-09-08

10.  Biofeedback vs. electrostimulation in the treatment of postdelivery anal incontinence: a randomized, clinical trial.

Authors:  Nazir Naimy; Anita Thomassen Lindam; Arne Bakka; Arne Engebritsen Faerden; Pål Wiik; Erik Carlsen; Britt-Ingjerd Nesheim
Journal:  Dis Colon Rectum       Date:  2007-10-04       Impact factor: 4.585

View more
  20 in total

Review 1.  Impact of fecal incontinence and its treatment on quality of life in women.

Authors:  Isuzu Meyer; Holly E Richter
Journal:  Womens Health (Lond)       Date:  2015-03

Review 2.  Bioengineering the gut: future prospects of regenerative medicine.

Authors:  Khalil N Bitar; Elie Zakhem
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-08-10       Impact factor: 46.802

Review 3.  Faecal incontinence: Current knowledges and perspectives.

Authors:  Alban Benezech; Michel Bouvier; Véronique Vitton
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

4.  Sacral neuromodulation for fecal incontinence in Latin America: initial results of a multicenter study.

Authors:  L Oliveira; G Hagerman; M L Torres; C M Lumi; J A C Siachoque; J C Reyes; J Perez-Aguirre; J C Sanchez-Robles; V H Guerrero-Guerrero; S M Regadas; V G Filho; G Rosato; E Vieira; L Marzan; D Lima; E Londoño-Schimmer; S D Wexner
Journal:  Tech Coloproctol       Date:  2019-06-12       Impact factor: 3.781

5.  Fecal Incontinence Symptoms and Impact in Older Versus Younger Women Seeking Care.

Authors:  Isuzu Meyer; Christina T Blanchard; Alayne D Markland; Elena G Gibson; Holly E Richter
Journal:  Dis Colon Rectum       Date:  2019-06       Impact factor: 4.585

6.  Ultrasonographic evidence of Gatekeeper™ prosthesis migration in patients treated for faecal incontinence: a case series.

Authors:  F de la Portilla; M L Reyes-Díaz; M V Maestre; R M Jiménez-Rodríguez; A M García-Cabrera; J M Vázquez-Monchul; J M Díaz-Pavón; F C Padillo-Ruiz
Journal:  Int J Colorectal Dis       Date:  2017-01-04       Impact factor: 2.571

7.  An evaluation of the long-term effectiveness of Gatekeeper™ intersphincteric implants for passive faecal incontinence.

Authors:  S A A Jabbar; J Camilleri-Brennan
Journal:  Tech Coloproctol       Date:  2022-05-20       Impact factor: 3.699

8.  The bother of anal incontinence and St. Mark's Incontinence Score.

Authors:  C Paka; I K Atan; H P Dietz
Journal:  Tech Coloproctol       Date:  2015-11-16       Impact factor: 3.781

9.  Aging-associated oxidative stress leads to decrease in IAS tone via RhoA/ROCK downregulation.

Authors:  Jagmohan Singh; Sumit Kumar; Chadalavada Vijay Krishna; Satish Rattan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-04-17       Impact factor: 4.052

10.  Validity of the ≥50% Response Threshold in Treatment With NASHA/Dx Injection Therapy for Fecal Incontinence.

Authors:  Jaime E Sanchez; Darren M Brenner; Howard Franklin; Jing Yu; Andrew C Barrett; Craig Paterson
Journal:  Clin Transl Gastroenterol       Date:  2015-01-15       Impact factor: 4.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.